Device and method of 3-dimensionally generating in vitro blood vessels

US9617520B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9617520-B2
Application numberUS-201514855513-A
CountryUS
Kind codeB2
Filing dateSep 16, 2015
Priority dateAug 31, 2006
Publication dateApr 11, 2017
Grant dateApr 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Apparatuses, systems, and methods for generating concentration gradients of soluble molecules are disclosed herein. Devices and methods for generating in vitro blood vessels are also disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of generating a blood vessel comprising: a) injecting i) gel and an extracellular matrix (ECM) and ii) a blood vessel-forming cell into a blood vessel-forming channel of a blood vessel-generating device comprising a) a sink channel in fluid communication with a sink inlet, b) a source channel in fluid communication with a source inlet parallel to the sink channel, c) the blood vessel-forming channel in fluid communication with a blood vessel-forming channel inlet, disposed in contact with the sides of the sink channel and the source channel between the sink channel and the source channel, parallel to the source channel and the sink channel, d) a first culture channel in fluid communication with a first culture channel inlet, disposed in contact with the other side of the sink channel, parallel to the sink channel and e) a second culture channel in fluid communication with a second culture channel inlet, disposed in contact with the other side of the source channel, parallel to the source channel, wherein a plurality of microstructures configured to allow interaction between biochemical materials included in each channel are arranged in interfaces of the respective adjacent channels at set intervals, and wherein the sink channel is disposed between the blood vessel-forming channel and the first culture channel, and the source channel is disposed between the blood vessel-forming channel and the second culture channel; b) injecting the ECM and a co-culturing cell into the first culture channel and/or the second culture channel of the blood vessel-generating device; and c) injecting an angiogenesis factor and/or a cell culture medium into the sink channel and/or the source channel of the blood vessel-generating device, and culturing the blood vessel-forming cell and the co-culturing cell; and d) interacting the blood vessel-forming cell with the co-culturing cell via paracrine signaling. 2. A method of generating a blood vessel comprising: a) injecting a gel and an extracellular matrix (ECM) into a blood vessel-forming channel of a blood vessel-generating device comprising a) a sink channel in fluid communication with a sink inlet, b) a source channel in fluid communication with a source inlet parallel to the sink channel, c) the blood vessel-forming channel in fluid communication with a blood vessel-forming channel inlet, disposed in contact with the sides of the sink channel and the source channel between the sink channel and the source channel, parallel to the source channel and the sink channel, d) a first culture channel in fluid communication with a first culture channel inlet, disposed in contact with the other side of the sink channel, parallel to the sink channel and e) a second culture channel in fluid communication with a second culture channel inlet, disposed in contact with the other side of the source channel, parallel to the source channel, wherein a plurality of microstructures configured to allow interaction between biochemical materials included in each channel are arranged in interfaces of the respective adjacent channels at set intervals, and wherein the sink channel is disposed between the blood vessel-forming channel and the first culture channel, and the source channel is disposed between the blood vessel-forming channel and the second culture channel; b) injecting a blood vessel-forming cell into the sink channel and/or the source channel of the blood vessel-generating device, and attaching the blood vessel-forming cell to the gel and/or the ECM exposed between the microstructures arranged in the sides of the blood vessel-forming channel; c) injecting the ECM and a co-culturing cell into the first culture channel and/or the second culture channel of the blood vessel-generating device; and d) injecting an angiogenesis factor and a cell culture medium into the sink channel and/or the source channel of the blood vessel-generating device, and culturing the blood vessel-forming cell and the co-culturing cell; e) interacting the blood vessel-forming cell with the co-culturing cell via paracrine signaling. 3. The method according to claim 1 or 2 , wherein the blood vessel-forming cell is at least one selected from the group consisting of an endothelial cell, an epithelial cell and a cancer cell. 4. The method according to claim 1 or 2 , wherein the gel is at least one selected from the group consisting of a collagen gel, a fibrin gel, a self-assembled peptide gel, a polyethylene glycol gel and an alginate gel. 5. The method according to claim 1 or 2 , wherein the co-culturing cell is at least one selected from the group consisting of an astrocyte, a glial cell, a mesothelial cell, a fibroblast, a smooth muscle cell and a cancer cell.

Assignees

Inventors

Classifications

  • C12N5/0691Primary

    Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels · CPC title

  • Scaffolds; Matrices (in general C12N5/0068) · CPC title

  • Perfusion · CPC title

  • Regulators of development · CPC title

  • Polysaccharides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9617520B2 cover?
Apparatuses, systems, and methods for generating concentration gradients of soluble molecules are disclosed herein. Devices and methods for generating in vitro blood vessels are also disclosed.
Who is the assignee on this patent?
Snu R&Db Foundation
What technology area does this patent fall under?
Primary CPC classification C12N5/0691. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).